|
|
|
Insider
Information: |
Hodges Mauri K |
Relationship: |
Officer |
City: |
Winston-Salem |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
41,259 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$21,096 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
41,259 |
|
|
Total
Value |
$21,096 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gyre Therapeutics |
GYRE |
Officer |
2014-12-11 |
41,259 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GYRE |
Gyre Therapeutics |
VP, Fin. & Admin., CFO, Treas. |
|
2014-12-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
41,259 |
|
- |
|
GYRE |
Gyre Therapeutics |
VP, Fin. & Admin., CFO, Treas. |
|
2014-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,159 |
|
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-07 |
4 |
S |
$30.00 |
$15,001 |
D/D |
(500) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-07 |
4 |
OE |
$5.55 |
$2,775 |
D/D |
500 |
1,659 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-03 |
4 |
OE |
$5.55 |
$27,917 |
D/D |
5,030 |
6,189 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-03 |
4 |
S |
$30.00 |
$150,900 |
D/D |
(5,030) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-02 |
4 |
S |
$30.00 |
$6,000 |
D/D |
(200) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-02 |
4 |
OE |
$5.55 |
$1,110 |
D/D |
200 |
1,359 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-01 |
4 |
S |
$30.16 |
$383,144 |
D/D |
(12,703) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2011-03-01 |
4 |
OE |
$5.55 |
$70,502 |
D/D |
12,703 |
13,862 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-12-16 |
4 |
S |
$25.24 |
$68,142 |
D/D |
(2,700) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-12-16 |
4 |
OE |
$8.51 |
$22,977 |
D/D |
2,700 |
3,859 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-05 |
4 |
S |
$25.01 |
$35,014 |
D/D |
(1,400) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-05 |
4 |
OE |
$8.51 |
$11,914 |
D/D |
1,400 |
2,559 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-04 |
4 |
S |
$25.08 |
$195,605 |
D/D |
(7,800) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-04 |
4 |
OE |
$8.51 |
$66,378 |
D/D |
7,800 |
8,959 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-03 |
4 |
OE |
$8.51 |
$8,510 |
D/D |
1,000 |
2,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Fin + Corp Sys & Controller |
|
2010-11-03 |
4 |
S |
$25.06 |
$25,055 |
D/D |
(1,000) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Finance & Controller |
|
2010-05-13 |
4 |
S |
$25.00 |
$35,050 |
D/D |
(1,402) |
1,159 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Finance & Controller |
|
2010-05-13 |
4 |
OE |
$8.51 |
$11,931 |
D/D |
1,402 |
2,561 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP Finance & Corp SystemsOffic |
|
2010-04-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,159 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|